Robert K. Zeldin - 21 Feb 2023 Form 4 Insider Report for MeiraGTx Holdings plc (MGTX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Robert J. Wollin, Attorney-in-Fact for Robert K. Zeldin
Issuer symbol
MGTX
Transactions as of
21 Feb 2023
Transactions value $
$0
Form type
4
Filing time
23 Feb 2023, 15:59:59 UTC
Previous filing
18 Jan 2023
Next filing
18 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTX Stock Option (Right to Buy) Award $0 +30,000 $0 30,000 21 Feb 2023 Ordinary Shares 30,000 $8.6 Direct F1
transaction MGTX Restricted Share Units Award $0 +30,000 $0 30,000 21 Feb 2023 Ordinary Shares 30,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to one quarter of the total grant on February 21, 2024 and vests as to the remainder in 36 equal monthly installments thereafter.
F2 Each restricted share unit converts into one ordinary share upon vesting.
F3 Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.